Clinical trials recruiting for MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
11
Recruiting trials
11
US states with sites
8
Countries
45%
Accept healthy volunteers
Phase breakdown
Phase 2 3Not applicable 8
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Lactiplantibacillus plantarum Probiotic Mixture | 1 |
| Pectin | 1 |
| Resmetirom | 1 |
| bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Alabama | 1 |
| Florida | 1 |
| Indiana | 1 |
| Maryland | 1 |
| Missouri | 1 |
| New York | 1 |
| North Carolina | 1 |
| Texas | 1 |
| Virginia | 1 |
| Washington | 1 |
Top cities
La Jolla, California 2Baltimore, Maryland 1Birmingham, Alabama 1Durham, North Carolina 1Houston, Texas 1Indianapolis, Indiana 1New York, New York 1Richmond, Virginia 1San Francisco, California 1Seattle, Washington 1
Self-screener
Recruiting trials
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- Cardiac Dysfunction in Patients with Fatty Liver Disease
- Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
- Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
- Effect of Ketone Esters on Liver Fat Content and Metabolic Function
- Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
- Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
- Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
- The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers
Related conditions
Trials recruiting for MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease often also study these conditions. Each links to its own recruiting-trial list.
NASH 218Obesity 1512MASLD 15NAFLD (Nonalcoholic Fatty Liver Disease) 5NAFLD - Non-Alcoholic Fatty Liver Disease 6Heart failure 1021Fatty Liver 17Pulmonary Disease, Chronic Obstructive (COPD) 4Overweight (BMI > 25) 4Overweight (BMI > 25) 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.